Status:
COMPLETED
Feasibility Study of the Taïso Practice in Parkinson's Disease
Lead Sponsor:
University Hospital, Angers
Conditions:
Parkinson Disease
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This is a pilot study of descriptive and analytical, prospective feasibility, monocentric, longitudinal with 6 months of bi-weekly practice of Taïso in patients with Parkinson's disease with mild to m...
Eligibility Criteria
Inclusion
- Age ≥18 and \<85 years old,
- Parkinson's disease diagnosed by a neurologist, treated and sensitive to dopaminergic treatment without limitation of the duration of the disease since the date of diagnosis,
- Patient with mild to moderate postural instability (equivalent to grade 2.5 and 3 on the Hoehn and Yahr scale),
- Naive patient of any practice of Taiso,
- Patient available to perform the Taïso program planned in the study,
- Patient with written informed consent
Exclusion
- Patient with a contraindication to the practice of sport
- Pregnant woman, parturient and breastfeeding mother
- Patient deprived of liberty by administrative or judicial decision
- Patient admitted to a health or social facility for purposes other than that of research
- Adults under guardianship or trusteeship or unable to express consent
- Patient not affiliated to a social security system
- Patient already participating in a therapeutic research protocol that aims to improve physical or mental abilities
Key Trial Info
Start Date :
September 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 7 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04045925
Start Date
September 9 2020
End Date
April 7 2021
Last Update
July 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU d'Angers
Angers, France, 49000